Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00429442
Recruitment Status : Withdrawn
First Posted : January 31, 2007
Last Update Posted : February 20, 2014
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
Anna Tsakiri, Glostrup University Hospital, Copenhagen

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Primary Completion Date : No date given
Estimated Study Completion Date : March 2011